Sleep disorders in dialysis patients

International Journal of Artificial Organs

Volumn 31, Issue 11, 2008, Pages 919-927

  Kosmadakis, Georgis Ch ^a   Medcalf, J F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Hemodialysis; Insomnia; Peritoneal dialysis; Restless legs syndrome; Sleep apnea; Sleep disorders

Indexed keywords

DISEASES; HEMODIALYZERS; PATIENT TREATMENT; SLEEP RESEARCH;

DAYTIME SLEEPINESS; END-STAGE RENAL DISEASE; HAEMODIALYSIS; INSOMNIA; PERITONEAL DIALYSIS; PROGNOSTIC FACTORS; RESTLESS LEG SYNDROMES; SLEEP APNEA; SLEEP DISORDERS; SLEEP-RELATED BREATHING DISORDERS;

DIALYSIS;

ALCOHOL; BENZODIAZEPINE; CABERGOLINE; CAFFEINE; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERYTHROPOIETIN; GABAPENTIN; IRON; LEVODOPA; METHADONE; OPIATE DERIVATIVE; OREXIN; PARATHYROID HORMONE; PERGOLIDE; PHOSPHORUS; PRAMIPEXOLE; RECOMBINANT ERYTHROPOIETIN; ROPINIROLE; ZALEPLON; ZOLPIDEM;

ACUPRESSURE; ANEMIA; BEDTIME DOSAGE; BEVERAGE; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; DRUG MEGADOSE; HEART MUSCLE FIBROSIS; HEMODIALYSIS PATIENT; HUMAN; INSOMNIA; KIDNEY FAILURE; LOW DRUG DOSE; MOTOR DYSFUNCTION; PATHOGENESIS; PERIODIC LIMB MOVEMENT DISORDER; PERITONEAL DIALYSIS; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PSYCHOLOGICAL ASPECT; RESTLESS LEGS SYNDROME; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT; UREMIA; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

EID: 59549101099     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101101     Document Type: Review

References (64)

1. Spiegel BM, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol 2008; 3: 1759-68.
2. Iliescu EA, Coo H, McMurray MH, et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 126-32.
3. Novak M, Shapiro CM, Mendelssohn D, Mucsi I. Diagnosis and management of insomnia in dialysis patients. Semin Dial 2006; 19: 25-31.
4. Molnar MZ, Novak M, Mucsi I. Management of restless legs syndrome in patients on dialysis. Drugs 2006; 66: 607-24.
5. Wen-Ching C, Paik-Seong L, Wen-Chieh W, et al. Sleep behavior disorders in a large cohort of Chinese (Taiwanese) patients maintained by long-term hemodialysis. Am J Kidney Dis 2006; 48: 277-84.
6. Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006; 21: 184-90.
7. Hanly P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial 2004; 17: 109-14.
8. Tada T, Kusano KF, Ogawa A, et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 2007; 22: 1190-7.
9. Rodriguez A, Stewart D, Hotchkiss M, Farrell P, Kliger A, Finkelstein F. Sleep apnea in CAPD. Adv Perit Dial 1995; 11: 123-6.
10. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis 1992; 19: 156-61.
11. Kawauchi A, Inoue Y, Hashimoto T, et al. Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis. Clin Nephrol 2006; 66: 440-6.
12. Mucsi I, Molnar MZ, Ambrus C, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 2005; 20: 571-7.
13. Stradling JR, Davies RJ. Sleep 1: obstructive sleep apnoea hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax 2004; 59: 73-8.
14. Unruh ML, Hartunian MG, Chapman MM, Jaber BL. Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol 2003; 59: 280-8.
15. De Santo RM, Bartiromo M, Cesare MC, Di Iorio BR. Sleeping disorders in early chronic kidney disease. Semin Nephrol 2006; 26: 64-7.
16. Novak M, Molnar MZ, Ambrus C, et al. Chronic insomnia in kidney transplant recipients. Am J Kidney Dis 2006; 47: 655-65.
17. Gigli GL, Adorati M, Dolso P, et al. Restless legs syndrome in end-stage renal disease. Sleep Med 2004; 5: 309-15.
18. Parker KP, Kutner NG, Bliwise DL, Bailey JL, Rye DB. Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis. Health Qual Life Outcomes 2003; 1: 68.
19. Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis 1999; 34: 1089-95.
20. Kuhlmann U, Becker HF, Birkhahn M, et al. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 2000; 53: 460-6.
21. Netzer N, Stoohs R, Netzer C, Clark K, Strohl K. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485-91.
22. The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-32.
23. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-19.
24. De Santo RM, Lucidi F, Violani C, Di Iorio BR. Sleep disorders in hemodialyzed patients: the role of comorbidities. Int J Artif Organs 2005; 28: 557-65.
25. Sabbatini M, Minale B, Crispo A, et al. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant 2002; 17: 852-6.
26. Lui SL, Ng F, Lo WK. Factors associated with sleep disorders in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2002; 22: 677-82.
27. De Santo RM, Esposito MG, Cesare CM, et al. High prevalence of sleep disorders in hemodialyzed patients requiring parathyroidectomy. J Ren Nutr 2008; 18: 52-5.
28. Parker KP, Bliwise DL, Rye DB. Hemodialysis disrupts basic sleep regulatory mechanisms: building hypotheses. Nurs Res 2000; 49: 327-32.
29. Williams SW, Tell GS, Zheng B, Shumaker S, Rocco MV, Sevick MA. Correlates of sleep behaviour among hemodialysis patients. The Kidney Outcomes Prediction and Evaluation (KOPE) study. Am J Nephrol 2002; 22: 18-28.
30. Rayner HC. Orexin as a possible cause of insomnia in dialysis patients. Am J Kidney Dis 2003; 41: 1335-6.
31. Vaziri ND, Oveisi F, Wierszbiezki M, Shaw V, Sporty LD. Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: effect on hemodialysis. Artif Organs 1993; 17: 764-9.
32. Pfister M, Jakob SM, Marti HP, Frey FJ, Gugger M. Ambulatory nocturnal oximetry and sleep questionnaire-based findings in 38 patients with end-stage renal disease. Nephrol Dial Transplant 1999; 14: 1496-502.
33. Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane PA, Hanly PJ. Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea. Eur Respir J 2007; 30: 965-71.
34. Pierson DJ. Respiratory considerations in the patient with renal failure. Respir Care 2006; 51: 413-22.
35. de Oliveira Rodrigues CJ, Marson O, Tufic S, et al. Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients. Am J Hypertens 2005; 18 (2 Pt 1): 152-7.
36. Beecroft J, Duffin J, Pierratos A, Chan CT, McFarlane P, Hanly PJ. Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 2006; 28: 151-7.
37. Parker KP, Bliwise DL, Bailey JL, Rye DB. Polysomnographic measures of nocturnal sleep in patients on chronic, intermittent daytime haemodialysis vs those with chronic kidney disease. Nephrol Dial Transplant 2005; 20: 1422-8.
38. Jean G, Piperno D, Francois B, Charra B. Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron 1995; 71: 138-42.
39. Kraus MA, Hamburger RJ. Sleep apnea in renal failure. Adv Perit Dial 1997; 13: 88-92.
40. Siafakas NM, Argyrakopoulos T, Andreopoulos K, Tsoukalas G, Tzanakis N, Bouros D. Respiratory muscle strength during continuous ambulatory peritoneal dialysis (CAPD). Eur Respir J 1995; 8: 109-13.
41. Kavanagh D, Siddiqui S, Geddes CC. Restless legs syndrome in patients on dialysis. Am J Kidney Dis 2004; 43: 763-71.
42. Unruh ML, Levey AS, D'Ambrosio C, Fink NE, Powe NR, Meyer KB. Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis 2004; 43: 900-9.
43. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002; 17: 1072-6.
44. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia: a neglected cardiovascular risk factor in end-stage renal disease? Blood Purif 2002; 20: 120-3.
45. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA. Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant 2001; 16: 70-7.
46. Zoccali C, Benedetto FA, Tripepi G, et al. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int 1998; 53: 1078-84.
47. American Sleep Association. Home page. http://www.sleep-association.org/. Accessed Nov 17, 2008
48. Tsay SL, Cho YC, Chen ML. Acupressure and transcutaneous electrical acupoint stimulation in improving fatigue, sleep quality and depression in hemodialysis patients. Am J Chin Med 2004; 32: 407-16.
49. Sabbatini M, Crispo A, Pisani A, et al. Zaleplon improves sleep quality in maintenance hemodialysis patients. Nephron Clin Pract 2003; 94: 99-103.
50. Fillastre JP, Geffroy-Josse S, Etienne I, et al. Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patients. Fundam Clin Pharmacol 1993; 7: 1-9.
51. Winkelmayer WC, Mehta J, Wang PS. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int 2007; 72: 1388-93.
52. Novak M, Mendelssohn D, Shapiro CM, Mucsi I. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin Dial 2006; 19: 210-6.
53. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-7.
54. Tang SC, Lam B, Ku PP, et al. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler: assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2607-16.
55. Soreide E, Skeie B, Kirvela O, et al. Branched-chain amino acid in chronic renal failure patients: respiratory and sleep effects. Kidney Int 1991; 40: 539-43.
56. Clavadetscher SC, Gugger M, Bassetti CL. Restless legs syndrome: clinical experience with long-term treatment. Sleep Med 2004; 5: 495-500.
57. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004; 43: 663-70.
58. Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, et al. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO J 2008; 54: 185-90.
59. Pieta J, Millar T, Zacharias J, Fine A, Kryger M. Effect of pergolide on restless legs and leg movements in sleep in uremic patients. Sleep 1998; 21: 617-22.
60. Worthington A, Thomas L. Valvular heart disease associated with taking low-dose pergolide for restless legs syndrome. Eur J Echocardiogr 2008; 9: 828-30.
61. Janzen L, Rich JA, Vercaigne LM. An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy. Ann Pharmacother 1999; 33: 86-92.
62. Pellecchia MT, Vitale C, Sabatini M, et al. Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release. Clin Neuropharmacol 2004; 27: 178-81.
63. Ondo WG. Methadone for refractory restless legs syndrome. Mov Disord 2005; 20: 345-8.
64. Thorp ML, Morris CD, Bagby SP. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 2001; 38: 104-8.